National Comprehensive Cancer Network

| |
|
|
For Patients

Educational Events & Programs

NCCN 4th Annual Congress:
Hematologic Malignancies™
Supporting Organizations

This Congress is supported by educational grants from Bayer HealthCare Pharmaceuticals, Inc.; Celgene Corporation; Cephalon Oncology; Eisai Inc.; Genzyme; GlaxoSmithKline; Merck Oncology; Millennium: The Takeda Oncology Company; Novartis Oncology; and sanofi aventis U.S.


NCCN appreciates that these supporting companies recognize NCCN’s need for autonomy in the development of the content of NCCN programs and resources. All NCCN content is produced completely independently.